Yield10 Bioscience, Inc.
YTENQ
$0.015
$0.000.00%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 450.00K | 300.00K | 0.00 | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 450.00K | 300.00K | 0.00 | -- | -- |
| Cost of Revenue | 1.53M | 1.37M | 1.96M | 2.20M | 1.86M |
| Gross Profit | -1.08M | -1.07M | -1.96M | -2.20M | -1.86M |
| SG&A Expenses | 2.00M | 1.37M | 1.29M | 1.50M | 1.67M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.65M | 2.74M | 3.25M | 3.70M | 3.67M |
| Operating Income | -3.20M | -2.44M | -3.25M | -3.70M | -3.67M |
| Income Before Tax | -3.24M | -2.47M | -3.27M | -3.73M | -3.68M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.24M | -2.47M | -3.27M | -3.73M | -3.68M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.24M | -2.47M | -3.27M | -3.73M | -3.68M |
| EBIT | -3.20M | -2.44M | -3.25M | -3.70M | -3.67M |
| EBITDA | -3.14M | -2.37M | -3.17M | -3.63M | -3.59M |
| EPS Basic | -5.04 | -4.77 | -6.54 | -9.95 | -15.42 |
| Normalized Basic EPS | -3.15 | -2.98 | -4.09 | -6.22 | -9.64 |
| EPS Diluted | -5.04 | -4.77 | -6.54 | -9.95 | -15.42 |
| Normalized Diluted EPS | -3.15 | -2.98 | -4.09 | -6.22 | -9.64 |
| Average Basic Shares Outstanding | 642.40K | 518.50K | 499.20K | 374.50K | 238.70K |
| Average Diluted Shares Outstanding | 642.40K | 518.50K | 499.20K | 374.50K | 238.70K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
